Self-amplifying RNA SARS-CoV-2 lipid nanoparticle vaccine candidate induces high neutralizing antibody titers in mice
2020 · Nature Communications · 460 citations
https://doi.org/10.1038/s41467-020-17409-9
P
Paulo J.C. Lin
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
96
Papers
6.6K
Citations
36
h-index
51
i10-index
Paulo J.C. Lin is an academic researcher from Acuitas Therapeutics (Canada). The author has contributed to research in topics: RNA Interference and Gene Delivery & SARS-CoV-2 and COVID-19 Research & Immunotherapy and Immune Responses. The author has an h-index of 36, co-authored 82 publications.
Papers by this author
worksIn vivo adenine base editing of PCSK9 in macaques reduces LDL cholesterol levels
2021 · Nature Biotechnology · 359 citations
https://doi.org/10.1038/s41587-021-00933-4
The Cellular Mechanisms of Neuronal Swelling Underlying Cytotoxic Edema
2015 · Cell · 251 citations
https://doi.org/10.1016/j.cell.2015.03.029
Molecular fate-mapping of serum antibody responses to repeat immunization
2023 · Nature · 168 citations
https://doi.org/10.1038/s41586-023-05715-3
Protein corona: implications for nanoparticle interactions with pulmonary cells
2017 · Particle and Fibre Toxicology · 119 citations
https://doi.org/10.1186/s12989-017-0223-3
ESCRT recruitment to SARS-CoV-2 spike induces virus-like particles that improve mRNA vaccines
2023 · Cell · 88 citations
https://doi.org/10.1016/j.cell.2023.04.024
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat